- Messages
- 67
- Likes
- 642
Yes, my daughter, my son and I all got what seemed to be an acute viral infection followed by ME symptoms, all at roughly the same time. Although our symptoms were very very similar, there wasn't much in our (non-comprehensive) blood tests that was consistent. My daughter has since regained nearly full health.
The high anion gaps are one of the few blood test result anomalies my son and I share. My albumin levels are consistently low, my son's are consistently high-normal, whereas his levels of ALT and ALP are consistently low.
My CRP levels are consistently moderately elevated, my son's are not. My son's white cell, lymphocyte and neutrophil counts are consistently low normal to low; mine are not. Our iron tests look very different from each other and over time, except that transferrin saturation is consistently high in both of us.
One of the few advantages of having multiple family members contract this illness at the same time is that a whole range of hypotheses that would have looked very plausible with a sample size of one just don't stand up with a sample size of three.
Chris, yes, please do let us know via this forum when you are recruiting for your next studies. Best wishes for attracting funding - hopefully the excitement over the Rituximab results translates into increased funding for all types of ME biomedical research.
The high anion gaps are one of the few blood test result anomalies my son and I share. My albumin levels are consistently low, my son's are consistently high-normal, whereas his levels of ALT and ALP are consistently low.
My CRP levels are consistently moderately elevated, my son's are not. My son's white cell, lymphocyte and neutrophil counts are consistently low normal to low; mine are not. Our iron tests look very different from each other and over time, except that transferrin saturation is consistently high in both of us.
One of the few advantages of having multiple family members contract this illness at the same time is that a whole range of hypotheses that would have looked very plausible with a sample size of one just don't stand up with a sample size of three.
Chris, yes, please do let us know via this forum when you are recruiting for your next studies. Best wishes for attracting funding - hopefully the excitement over the Rituximab results translates into increased funding for all types of ME biomedical research.